In thisautomated procedure for quantifying biotinidase activity in human serum, a manual colorimetric method that measures conversion of the enzyme's artificial substrate Nbiotinyl p-aminobenzoate was modified for use with a Technicon AutoAnalyzer II. The intra-run replicate precision (CV) was 2.1% and the day-to-day CV was 4.6% for quality-control sera. Results were linearly related to biotinidase activity in serum over the complete range of clinically relevant values, 0.2 to 11.0 U/L. Moreover, results of the automated assay were not significantly different from those of the manual assay. Because the automated procedure is faster and more precise, we recommend it for population-based studies and some screening studies. after coupling an azo compound to the diazonium salt of the PABA produced.6 Although this manual procedure is reliable and reproducible (2), one can assay only a few specimens with it simultaneously. Because we sought a more rapid and precise method that could be applied to population and screening studies in which many serum samples are to be examined, we adapted the manual method to a continuous-flow procedure. Here we describe the method, and evaluate its speed, precision, accuracy, and applicability to genetic and epidemiological studies. sis. We also obtained 14 specimens from two children with biotinidase deficiency and from some of their family members. Serum quality-control material was prepared by pooling freshly prepared sera from nine healthy adults, and stored at -70 #{176}C. The biotinidase activity of this pooled sample did not differ significantly from the mean activity of normal control samples. Lyophilized pooled serum (Ciba Corning Diagnostics Corp., Irvine, CA) was used as a lowactivity quality-control specimen.
Additional Keyphrases: cant inuous-flow analysis . heritable disorders . screening Biotinidase (EC 3.5.1.12) activity is usually measured in human serum by a modification of the procedure of Knappe et al. (1) . The quantity of p-aminobenzoic acid (PABA) released from the artificial substrate, N-biotinyl-p-anunobenzoate (BPAB), is determined colorimetrically after coupling an azo compound to the diazonium salt of the PABA produced.6 Although this manual procedure is reliable and reproducible (2) , one can assay only a few specimens with it simultaneously. Because we sought a more rapid and precise method that could be applied to population and screening studies in which many serum samples are to be examined, we adapted the manual method to a continuous-flow procedure. Here we describe the method, and evaluate its speed, precision, accuracy, and applicability to genetic and epidemiological studies. Figure 1 . In the automated method we used the same concentrations of reagents as in the manual method except that we added5 mL of the wetting agent to each liter of buffer and 0.5 mL of Triton X-100 (Sigma) to each liter of the other reagents.
Materials and Methods

Chemicals
We also used HC1 (1 mol/L) instead of trichioroacetic acid to inactivate the enzyme and to decrease the pH to 1.8-2.0, which is necessary for development of color.
In the automated procedure, serum was incubated at 37#{176}C with potassium phosphate buffer (50 mmol/L, pH 6.0) containing EDTA ( Color was developed by the same procedure used in the manual assay. Absorbance at 550 urn was measured colonmetrically, and recorded continuously on a strip-chart recorder at a chart speed of 2.5 cm/mm. Triplicate aliquots of PABA standard (0.2 mmoLfL) were assayed at the beginning and end of each run. The withinrun mean peak height of these samples was used for calculating biotinidase activity, as follows:
PABA in serum = (peak height of serum sample/mean peak height of PABA) x 200
One unit of biotinidase activity (U) is equivalent to the release of 1 Mmol of PABA from BPAB per minute at 37#{176}C.
Evaluation of the automated procedure.
To determine the range of activities over which the response of the colorimeter remained linear, we diluted pooled control serum with 0.15 mol/L sodium chloride solution containing human serum albumin (4 g/L) and assayed the resulting solutions.
We measured the percentage of carryover of activity by sampling and assaying three low-activity quality-control specimens after three high-activity quality-control specimens on four separate occasions.
To evaluate precision, we used samples of the high-and low-activity quality-control specimens. Each sample was assayed in duplicate on each of 16 days spanning an eightmonth period. Precision was also evaluated by calculating the sources of variation for data obtained from the subjects' specimens. Sera from groups of five different individuals were tested on each of 16 days. To estimate the variation within subjects, blood was drawn from each of four healthy volunteers three times per week for six weeks. Serum was prepared and stored until the end of the sampling period, and all specimens were thawed and assayed on a single day. Analysis of variance was used to estimate the proportions of total variance attributable to analytical error, variation within subjects, and variation among subjects (3).
Comparison of methods.
Biotinidase activity was measured in 111 serum specimens by both the manual and the automated assay procedures, on a total of 20 different days. Ninety-seven specimens were selected without conscious bias from a healthy adult population, and 14 specimens from two families with biotinidase-deficient children also were included. The mean activity of duplicate determinations on each sample was used for the method-comparison analysis. The differences between the values obtained by each method were evaluated using a paired t-test and the median values obtained for each method were compared by the Wibcoxon Rank Sum Test. The Deming regression of the estimates of biotinidase activities generated by the automated method on the estimates generated with the manual method was determined (4) and a Pearson correlation coefficient was calculated.
Results
Performance of the automated assay. Absorbance was linear (r = 1.00; P <0.0001) for pooled control serum, undiluted or diluted to give concentrations down to 62.5 mLIL for which the corresponding biotinidase activities were 7.5 to 0.48 U/L. The lower detection limit of the assay corresponds to 0.2 U/L. The upper limit, determined with PABA, is approximately 11.0 U/L. The mean carryover was 2.1%.
Precision and reproducibility.
The overall CVs for the high-and low-activity quality controls were 4.6% (n 138) and 9.0% (n = 64). The mean intra-run CVs were 2.1% and 5.2%. There was no significant decrease in the biotinidase activity of the control specimens during the eight-month study.
The within-run CV for the subjects'duplicate samples was 4.2%; the overall CV was 16.3%. Differences among subjects accounted for 93.8% of the total variance, and within-run analytical error among replicates accounted for the remaining 6.2%. There was no significant error associated with between-run variation.
Variation between and among subjects. The estimated biological variance, i.e., the sum of intra-and inter-individual variance components, was 0.76 (0.60 + 0.16). The highest estimate of analytical variance from the analysis was 0.12. Thus, the ratio of inter-individual variation to intra-individual plus analytical variation was 2.14 (0.60/ 0.28). If we excluded the analytical variation, then the ratio was 3.75. Hence, the variation between individuals is almost fourfold that within an individual.
Comparison of methods. The distributions of enzyme activities for each method were significantly 
Discussion
Biotinidase activities measured by the present procedure compared well with those from the manual assay, but the automated method is more precise. Within-run precision of assays on high-activity quality-control material and subjects' specimens was similar for both methods. For the lowactivity quality-control specimens, the within-run variation was lower with the automated assay. Total variance of the samples analyzed by the automated assay was lower than that for the manual method. Most of the difference in total variance between the manual and automated procedures is attributable to the difference in magnitude of the between-run variance which, for the later method, was negligible.
The activity determined by the automated procedure was linear for the complete range of clinically relevant activities biotimdase-deficient specimen in the autosampler. A sample cup containing phosphate buffer should be inserted between each sample suspected of having deficient or very low activity.
Interfering substances such as sulfonamides, if present in a sample, can cause color development, such that a biotimdase-deficient specimen could exhibit color corresponding to normal activity and a normal specimen could exhibit color corresponding to activity exceeding the upper lixmt of normal. Therefore, samples tested by either method also should be tested in the absence of substrate for the presence of other chromogenic compounds.
The applicability of the automated method to clinical, genetic, and epidemiological studies depends on the relative contributions of analytical and biological variation to total variation in activity, and on the relative contributions of intra-and inter-individual variation to total biological variation. Although there is no clear definition of "acceptable" analytical variation, Tonks (5) suggested that total analytical variation should not exceed one-fourth of the total biological variation. The analytical variation of the automated assay is sufficiently low (less than one-sixth of biological variation) to assure that true differences between subjects will not be obscured and that abnormal laboratory results will be identified reliably. The differences among individuals accounted for two to four times more variation than did variation within a single individual and, therefore, the automated system is acceptable for use in genetic and epidemiological studies.
This automated assay provides a reliable means for conveniently determining biotinidase activity in a large number of serum specimens, and results are more precise CLIN. CHEM. 35/5, 833-835 (1989) than with the manual assay. Thirty samples can be analyzed in an hour, whereas about 3 his required to analyze an equivalent number of samples by the manual method. Furthermore, because handling of the samples and reagents is minimized, there is less possibility of human error. The speed, precision, and reliability of the present procedure make it the preferred method for barge population-based studies of biotinidase activity in human serum.
